Polaris Wealth Advisory Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$216K Buy
+3,120
New +$251K 0.02% 161
2023
Q2
Sell
-3,120
Closed -$258K 159
2023
Q1
$258K Hold
3,120
0.02% 155
2022
Q4
$242K Hold
3,120
0.02% 161
2022
Q3
$258K Hold
3,120
0.02% 145
2022
Q2
$297K Hold
3,120
0.02% 121
2022
Q1
$386K Hold
3,120
0.03% 127
2021
Q4
$404K Sell
3,120
-99
-3% -$11.5K 0.02% 139
2021
Q3
$357K Hold
3,219
0.02% 134
2021
Q2
$337K Buy
3,219
+99
+3% +$9.33K 0.02% 135
2021
Q1
$268K Hold
3,120
0.02% 150
2020
Q4
$283K Sell
3,120
-720
-19% -$59.7K 0.02% 158
2020
Q3
$308K Sell
3,840
-9
-0.2% -$702 0.03% 127
2020
Q2
$266K Sell
3,849
-69
-2% -$4.9K 0.02% 127
2020
Q1
$246K Buy
3,918
+69
+2% +$4.98K 0.03% 106
2019
Q4
$306K Buy
+3,849
New +$301K 0.02% 128
2018
Q4
Sell
-1,440
Closed -$84K 245
2018
Q3
$84K Buy
+1,440
New +$70.4K 0.01% 213
2018
Q2
Sell
-1,440
Closed -$67K 313
2018
Q1
$67K Buy
+1,440
New +$62.5K 0.01% 199

Other funds holding EW

Polaris Wealth Advisory Group's EW Position: Q3 2023 in Review

Polaris Wealth Advisory Group opened a new position in Edwards Lifesciences (EW) in Q3 2023: 3,120 shares worth $216K. The stake represents 0.02% of the portfolio and ranks #161 among its holdings. This is a return to the name: Polaris Wealth Advisory Group previously reported a position in EW as recently as Q1 2023.

Polaris Wealth Advisory Group first reported a position in EW in Q1 2018 and has held it in 17 quarters since. The position peaked at $404K in Q4 2021. 1,220 funds tracked by Wall St. Rank hold EW as of Q3 2023.

  • Polaris Wealth Advisory Group held 3,120 shares of Edwards Lifesciences worth $216K as of Q3 2023.
  • Edwards Lifesciences was a new Polaris Wealth Advisory Group position in Q3 2023.
  • Edwards Lifesciences made up 0.02% of Polaris Wealth Advisory Group's portfolio in Q3 2023, its #161 holding.
  • Polaris Wealth Advisory Group first reported a position in Edwards Lifesciences in Q1 2018 and has held it in 17 quarters since.
  • Polaris Wealth Advisory Group's Edwards Lifesciences position peaked at $404K in Q4 2021.
  • 1,220 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on Polaris Wealth Advisory Group's 13F filing for Q3 2023, filed 11 Oct 2023.